The NWBO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NWBO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The NWBO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View NWBO Detailed Price Forecast - CNN Money | View NWBO Detailed Summary - Google Finance | ||
View NWBO Detailed Summary - Yahoo! Finance | View NWBO Stock Research & Analysis - Zacks.com |
View NWBO Trends & Analysis - Trade-Ideas | View NWBO Major Holders - Barrons | ||
View NWBO Call Transcripts - NASDAQ | View NWBO Breaking News & Analysis - Seeking Alpha | ||
View NWBO Annual Report - CompanySpotlight.com | View NWBO OTC Short Report - OTCShortReport.com | ||
View NWBO Fundamentals - TradeKing | View NWBO SEC Filings - Bar Chart | ||
View Historical Prices for NWBO - The WSJ | View Performance/Total Return for NWBO - Morningstar | ||
View the Analyst Estimates for NWBO - MarketWatch | View the Earnings History for NWBO - CNBC | ||
View the NWBO Earnings - StockMarketWatch | View NWBO Buy or Sell Recommendations - MacroAxis | ||
View the NWBO Bullish Patterns - American Bulls | View NWBO Short Pain Metrics - ShortPainBot.com |
View NWBO Stock Mentions - StockTwits | View NWBO Stock Mentions - PennyStockTweets | ||
View NWBO Stock Mentions - Twitter | View NWBO Investment Forum News - Investor Hub | ||
View NWBO Stock Mentions - Yahoo! Message Board | View NWBO Stock Mentions - Seeking Alpha |
View Insider Transactions for NWBO - SECform4.com | View Insider Transactions for NWBO - Insider Cow | ||
View NWBO Major Holdings Summary - CNBC | View Insider Disclosure for NWBO - OTC Markets | ||
View Insider Transactions for NWBO - Yahoo! Finance | View Institutional Holdings for NWBO - NASDAQ |
View NWBO Stock Insight & Charts - FinViz.com | View NWBO Investment Charts - StockCharts.com | ||
View NWBO Stock Overview & Charts - BarChart | View NWBO User Generated Charts - Trading View |
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors
Posted on Thursday March 21, 2024
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that it has appointed Mr. Pat Sarma to its Board of Directors effective March 18, 2024.
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
Posted on Tuesday February 06, 2024
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the key development work for the Flaskworks manufacturing system has been completed and an external vendor has been engaged to produce GMP-grade units of the system. In addition, the patent coverage of the Flaskworks system has been expanded: the foundational patent has been issued in the U.S. (and elsewhere) and an additional n
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma
Posted on Thursday December 21, 2023
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that a Marketing Authorization Application (MAA) was submitted yesterday to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK for DCVax®-L for glioblastoma brain cancer.
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Posted on Wednesday November 22, 2023
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, provided an update today about the final preparations for the Marketing Authorization Application (MAA) that will be submitted to the Medicines and Healthcare Products Regulatory Agency (MHRA)(the equivalent of the U.S. FDA) in the U.K. for commercial approval of the Company's DCVax®-L treatment for glioblastoma.